招聘
Essential Functions
- Prepare monthly rolling forecast
- Monitor and review variance between actual results, forecast, and budget/backlog for IQVIA Biotech.
- Coordinate with Project Leadership team/Project finance manager when required to address variance
- Analyse monthly business performance (by projects, region, function etc.) during revenue recognition weeks
- Provide management reports with insights and actionable recommendations
- Track and monitor key performance indicators (Utilization, Rev/FTE, etc.)
- Partner with BU management team to provide financial support including monthly financial review (1-1 sessions)
- Support department in understand the financial impact of decisions
- Conduct scenario planning and sensitivity analysis and support long-term strategic planning (FTE planning)
- Provide financial insights for special request (e.g. justification etc.) Prepare monthly revenue allocations and journals
- Assist with preparation of the monthly financial review deck for the region
- Develop and maintain financial templates Investigate and resolve accounting posting discrepancies
Requirements:
- Bachelor’s degree in accounting or relevant discipline
- At least 5 years of relevant experience in financial planning & analysis (FP&A), business finance, or management reporting, preferably in a project-based or matrix organization.
- Hands-on experience preparing and managing monthly rolling forecasts, budgets, and variance analysis.
- Experience with large ERP systems/ Peoplesoft preferred
- Knowledge of Microsoft Office applications
- Strong analytical and numeracy skills
- Effective verbal and written communication skills Professional qualification (e.g. ACCA, CPA, CA, CFA) is an advantage but not mandatory
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at https://jobs.iqvia.com
IQVIA is committed to integrity in our hiring process and maintains a zero tolerance policy for candidate fraud. All information and credentials submitted in your application must be truthful and complete. Any false statements, misrepresentations, or material omissions during the recruitment process will result in immediate disqualification of your application, or termination of employment if discovered later, in accordance with applicable law. We appreciate your honesty and professionalism.
总浏览量
0
申请点击数
0
模拟申请者数
0
收藏
0
相似职位

Director, SEA Tax
Applied Materials · Singapore, Singapore

Chief of Risk
Revolut · Singapore

Wealth Business Execution Specialist - AIMS (Vice President)
Citigroup · singapore

Asset Management - Equity Trading - Vice President
JPMorgan Chase · Singapore, Singapore, SG

Cluster Finance Director – HK, SG, TWN, INDO
Abbott · Singapore
关于IQVIA

IQVIA
PublicIQVIA Holdings, Inc. is an American company based in Durham, North Carolina, focused on health information technology and clinical research.
10,001+
员工数
Durham
总部位置
$17B
企业估值
评价
3.6
10条评价
工作生活平衡
3.8
薪酬
2.5
企业文化
4.0
职业发展
3.2
管理层
2.8
65%
推荐给朋友
优点
Good work-life balance
Supportive team and collaborative environment
Good benefits and flexible hours
缺点
Compensation below industry standards
High workload and overwhelming at times
Management communication and organization issues
薪资范围
45个数据点
Mid/L4
Mid/L4 · ANALYST
2份报告
$97,500
年薪总额
基本工资
$102,667
股票
-
奖金
-
$97,500
$97,500
面试经验
3次面试
难度
3.0
/ 5
时长
14-28周
体验
正面 0%
中性 33%
负面 67%
面试流程
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Technical Manager Interview
5
Executive/GM Interview
6
Offer
常见问题
Behavioral/STAR
Case Study
Technical Knowledge
Past Experience
Culture Fit
新闻动态
IQVIA Shareholders Approve New 2026 Incentive Plan - TipRanks
TipRanks
News
·
5d ago
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
MarketWatch
News
·
5d ago
The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags, boosting Novo's shares - Fierce Pharma
Fierce Pharma
News
·
5d ago
The outlook for obesity from 2026 to 2030 - IQVIA
IQVIA
News
·
1w ago